MF
TLSIW icon

Magnetar Financial’s TriSalus Life Sciences Warrant TLSIW Stock Holding History

Magnetar Financial’s Portfolio TLSIW Stock Details TLSIW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-642,163
Closed -$1.17M – 693
2024
Q2 		$1.17M Sell
642,163
-125,000
-16% -$170K 0.02% 249
2024
Q1 		$844K Sell
767,163
-112,346
-13% -$112K 0.02% 265
2023
Q4 		$941K Hold
879,509
– – 0.02% 261
2023
Q3 		$331K Sell
879,509
-329,993
-27% -$70.8K 0.01% 363
2023
Q2 		$58.1K Hold
1,209,502
– – ﹤0.01% 451
2023
Q1 		$96.1K Hold
1,209,502
– – ﹤0.01% 562
2022
Q4 		$60K Hold
1,209,502
– – ﹤0.01% 712
2022
Q3 		$73K Sell
1,209,502
-17,589
-1% -$1.26K ﹤0.01% 955
2022
Q2 		$103 Sell
1,227,091
-16,173
-1% -$3.09K ﹤0.01% 1320
2022
Q1 		$315K Buy
1,243,264
+668,921
+116% +$288K ﹤0.01% 988
2021
Q4 		$306K Buy
574,343
+396
+0.1% +$364 ﹤0.01% 1062
2021
Q3 		$471K Buy
+573,947
New +$533K ﹤0.01% 906

Other funds holding TLSIW

VI
Vestcor Inc Fredericton, New Brunswick, Canada $3.63B AUM 21.49% 1-Year Est. Return
FVWA
Foster Victor Wealth Advisors Greenville, South Carolina $1.75B AUM 18.02% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
ACM
Alpha Capital Management Austin, Texas $690M AUM 22.82% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Magnetar Financial's TLSIW Position: Q3 2024 in Review

Magnetar Financial sold out of TriSalus Life Sciences Warrant (TLSIW) in Q3 2024, closing a stake of 642,163 shares — an estimated $1.17M sold.

Magnetar Financial first reported a position in TLSIW in Q3 2021 and held it in 12 quarters. The position peaked at $1.17M in Q2 2024. 8 funds tracked by Wall St. Rank hold TLSIW as of Q3 2024.

  • Magnetar Financial reported no remaining TriSalus Life Sciences Warrant position as of Q3 2024 after selling out during the quarter.
  • Magnetar Financial sold 642,163 TriSalus Life Sciences Warrant shares in Q3 2024, an estimated $1.17M.
  • Magnetar Financial first reported a position in TriSalus Life Sciences Warrant in Q3 2021 and held it in 12 quarters.
  • Magnetar Financial's TriSalus Life Sciences Warrant position peaked at $1.17M in Q2 2024.
  • 8 funds tracked by Wall St. Rank held TriSalus Life Sciences Warrant as of Q3 2024.

Based on Magnetar Financial's 13F filing for Q3 2024, filed 13 Nov 2024.